Skip to main content

Specialty Pharmacy

  • Diplomat to dispense Zejula
    FLINT, Mich. — Diplomat Pharmacy on Wednesday announced that it had been selected to the specialty pharmacy panel dispensing Zejula (niraparib). The drug is a once-daily oral maintenance treatment indicated to treat women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
     
    Zejula is the first poly ADP-ribose polymerase inhibitor approved by the Food and Drug Administration that doesn’t require BRCA mutation or other biomarker testing, Diplomat said.
     

  • J&J’s Actelion acquisition expected to close this quarter

    NEW BRUNSWICK, N.J. — Johnson & Johnson confirmed Tuesday during its 2017 fiscal first-quarter earnings report that it expects its $30 billion acquisition of Actelion to close this quarter.

    “The public tender offer for Actelion has been declared successful based on the number of shares tendered and regulatory approval has been obtained in six of seven jurisdictions in which the company filed for such approval, with antitrust approval from the European Commission pending.”

  • FDA approves Genentech’s bladder cancer drug

    WASHINGTON — The Food and Drug Administration granted accelerated approval to Genentech’s Tecentriq (atezolizumab) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for cisplatin chemotherapy. Tecentriq was previously approved for people with locally advanced or mUC who have disease progression during or following any platinum-containing chemotherapy, or within 12 months of receiving chemotherapy before surgery (neoadjuvant) or after surgery (adjuvant).

  • Walgreens Healthcare Clinic to offer HIV, STI testing in multiple markets

    DEERFIELD, Ill. — Beginning April 25, Walgreens Healthcare Clinic locations in 18 markets will offer testing services for sexually transmitted infections, including HIV, Hepatitis B and C, chlamydia and gonorrhea.

  • Kroger: Eyeing growth opportunities

    Giant supermarket operator Kroger views health and wellness as an area for long-term investment, a point underscored by its purchase last year of specialty pharmacy ModernHEALTH. Even as it faces headwinds related to food deflation, Kroger is keeping an eye on growth opportunities in its expansive market area, which includes 35 states and the District of Columbia.

  • Diplomat promotes Cretu to support EnvoyHealth

    FLINT, Mich. — Diplomat Pharmacy is moving one of its executives to help support its Envoy Health Management business. Jennifer Cretu — most recently VP marketing and public relations — has been named SVP pharma services and marketing.

    In the new role, Cretu will manage pharma services for EnvoyHealth, which offers comprehensive program solutions for manufacturers to help bring their medications to market. She will continue overseeing Diplomat’s corporate communications, marketing and public relations.

  • Researchers propose new method of determining clinical trial effectiveness

    CAMBRIDGE, Mass. — Researchers at the Massachusetts Institute of Technology and Mayo Clinic have proposed a new way to determine if clinical trials are effective. The research was published in the Journal of American Medicine.

  • Diplomat appoints new CFO

    FLINT, Mich. — Diplomat Pharmacy on Tuesday named Atul Kavthekar as its CFO and treasurer, effective May 1. Kavthekar will head up Diplomat’s financial operations and investor relations, as well as managing the company’s liquidity, balance sheet risk and capital market transactions, reporting directly to CEO and chairman Phil Hagerman.

X
This ad will auto-close in 10 seconds